Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides medical services. Founded on 16 March 2000; wholly owned by Aversi-Pharma.
Subsidiary of Aversi-Pharma (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 8,767 | 11,344 | 11,995 | 18,490 | 26,253 | 25,688 | 29,612 | 31,367 | +20.0% |
| Net Cash used in Investing Activities | 0 | 8,508 | 9,044 | 9,741 | 23,798 | 14,087 | 13,986 | 32,330 | +24.9% |
| Free Cash Flow (OCF − Capex proxy) | 8,767 | 2,836 | 2,951 | 8,749 | 2,454 | 11,601 | 15,626 | 963 | nmf |
| Net Cash from Financing Activities | 0 | 0 | 4,119 | 6,119 | 6,133 | 511 | 8,554 | 5,282 | +5.1% |
| Net Change in Cash (before FX) | 8,767 | 2,836 | 1,168 | 2,630 | 3,679 | 11,090 | 7,072 | 6,245 | nmf |
| Effect of FX on Cash | 0 | 1 | 9 | 84 | 107 | 30 | 43 | 36 | nmf |
| Net Change in Cash (incl. FX) | 8,767 | 2,835 | 1,158 | 2,714 | 3,786 | 11,060 | 7,029 | 6,209 | nmf |
| Cash at Beginning of Year | 0 | 1,258 | 4,093 | 2,935 | 5,649 | 1,863 | 12,922 | 19,951 | +58.5% |
| Cash at End of Year | 0 | 4,093 | 2,935 | 5,649 | 1,863 | 12,922 | 19,951 | 13,743 | +22.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →